1.36
4.90%
-0.07
시간 외 거래:
1.36
Aptorum Group Ltd 주식(APM)의 최신 뉴스
Andean Precious Metals (CVE:APM) Upgraded at Desjardins - Defense World
Aptorum Group stock hits 52-week low at $1.35 amid market challenges - Investing.com India
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10 - AsiaOne
Andean Precious Metals (CVE:APM) Reaches New 1-Year High Following Insider Buying Activity - MarketBeat
Oncology And Infectious Diseases Focused Aptorum Stock Skyrockets 7X On WednesdayHere's Why - MSN
Aptorum Group Limited (NASDAQ:APM) Sees Large Growth in Short Interest - Defense World
Aptorum Group Limited (NASDAQ:APM) Short Interest Down 47.1% in July - Defense World
Aptorum Group Limited (NASDAQ:APM) Short Interest Update - Defense World
NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg
Aptorum Group (NASDAQ:APM) Trading Up 0.4% - Defense World
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update30.04.2024 - wallstreet:online
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Markets Insider
symbol__ Stock Quote Price and Forecast - CNN
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Markets Insider
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales - Benzinga
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a ... - sharewise
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023 - Business Wire
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets - Yahoo Finance
Aptorum Group Limited Announces Resignation of Thomas Lee as Head of Research and Development - Marketscreener.com
Why Is Aptorum (APM) Stock Down 16% Today? - InvestorPlace
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group - Business Wire
Menopause Market Size, Share And Trends Report, 2031 - SkyQuest Technology
Aptorum Group Announces 1-for-10 Reverse Stock Split - Business Wire
Cotações de Ações Americanas (STOCKS) - Money Times
DelveInsight Estimates a Promising Picture of Obesity Pipeline Space Landscape as Key 100+ Pharma Companies Working in the Space - PR Newswire
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics - ACROFAN
Notice to Boustead Securities Customers Who Purchased IPOs - GlobeNewswire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021 - Business Wire
Aptorum GroupAPMHigh RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run - The Market Oracle
NY-APTORUM-GROUP-LIMITED | Business Wire - Via Ritzau
Aptorum Gr (NASDAQ:APM) Stock Quotes, Forecast and News Summary - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
42 Stocks Moving in Thursday's Pre-Market SessionC3.ai (NYSE:AI) - Benzinga
40 Stocks Moving in Monday's Pre-Market SessionAMC Enter Hldgs (NYSE:AMC), Aptorum Gr (NASDAQ:APM) - Benzinga
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020 - businesswire.com
Aptorum Group Limited (NASDAQ:APM) Unveils Infectious Disease Liquid Biopsy Subsidiary to Co-develop RPIDD Tech - BP Journal
45 Stocks Moving in Wednesday's Pre-Market SessionAdial Pharmaceuticals (NASDAQ:ADIL), Aptorum Gr (NAS - Benzinga
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagnostics Technology To Track Pathogenic Geno - AsiaOne
Aptorum Group Ltd (NASDAQ:APM) Pleased To Unveil Video Indicating Positive Results On SACT-1 - BP Journal
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models - Business Wire
Sharp thinking in medicine | The Standard - Hong Kong Standard
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020 - AsiaOne
Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States - BioSpace
Argus Research Initiates Equity Research Report Coverage on Aptorum Group Limited (NasdaqGM: APM) - GlobeNewswire
Hong Kong pharma start-up joins Singapore technology agency in venture fund - South China Morning Post
USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations - Business Wire
Aptorum Group (APM) Stock Price, News & Analysis - MarketBeat
APM Stock Price and Chart — NASDAQ:APM - TradingView
Aptorum Group Limited Announces Closing of Initial Public Offering - Business Wire
Is biotech in Hong Kong doomed to fail, despite the sector’s potential? - South China Morning Post
자본화:
|
볼륨(24시간):